Purpose: The COVID-19 outbreak is affecting people worldwide. Many infected patients have respiratory involvement that may progress to acute respiratory distress syndrome. This pilot study aimed to evaluate the clinical efficacy of low-dose whole-lung radiation therapy in patients with COVID-19 pneumonia.
Methods And Materials: In this clinical trial, conducted in Iran, we enrolled patients with COVID-19 who were older than 60 years and hospitalized to receive supplementary oxygen for their documented pneumonia. Participants were treated with whole-lung irradiation in a single fraction of 0.5 Gy plus the national protocol for the management of COVID-19. Vital signs (including blood oxygenation and body temperature) and laboratory findings (interleukin-6 and C-reactive peptide) were recorded before and after irradiation.
Results: Between May 21, 2020 and June 24, 2020, 5 patients received whole-lung irradiation. They were followed for 5 to 7 days to evaluate the response to treatment and toxicities. The clinical and paraclinical findings of 4 of the 5 patients (patient 4 worsened and died on day 3) improved on the first day of irradiation. Patient 3 opted out of the trial on the third day after irradiation. The mean time to discharge was 6 days for the other 3 patients. No acute radiation-induced toxicity was recorded.
Conclusions: With a response rate of 80%, whole-lung irradiation in a single fraction of 0.5 Gy had encouraging results in oxygen-dependent patients with COVID-19 pneumonia.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7373065 | PMC |
| http://dx.doi.org/10.1016/j.ijrobp.2020.07.026 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Development of a protocol for whole-lung lung perfusion-assisted photodynamic therapy using a porcine model.
J Biomed Opt
November 2024
University of Toronto, Faculty of Medicine, Department of Medical Biophysics, Toronto, Ontario, Canada.
Significance: Standard treatments for isolated lung metastases remain a clinical challenge. lung perfusion technique provides flexibility to overcome the limitations of photodynamic therapy (PDT) by replacing the blood with acellular perfusate, allowing greater light penetration.
Aim: Using Monte Carlo-based simulations, we will evaluate the abilities of a light delivery system to irradiate the lung homogenously.
Regional variations in hyperpolarized 129Xe lung MRI: Insights from CSI-CSSR and CSSR in healthy and irradiated rat models.
Magn Reson Med
March 2025
Department of Radiology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Purpose: To compare pulmonary function metrics obtained with hyperpolarized xenon-129 (HXe) MRS, using chemical shift saturation recovery (CSSR) and CSI-CSSR, in healthy rats and a rat model of radiation-induced lung injury.
Methods: HXe-MR data were acquired in two healthy rats and one rat with radiation-induced lung injury using whole-lung spectroscopy and CSI-CSSR techniques. The CSI-CSSR acquisitions were performed with both fixed TE and variable TE.
Metastatic-Site Radiation Therapy for Ewing Sarcoma and Rhabdomyosarcoma: Consensus Guidelines From the National Pediatric Cancer Foundation.
Pract Radiat Oncol
October 2024
Department of Radiation Oncology, Vanderbilt University Medical Center, Nashville, Tennessee.
Purpose: Despite the urgent need for improved outcomes in patients with metastatic Ewing sarcoma (EWS) and rhabdomyosarcoma (RMS), it is unknown how to best approach metastatic-site radiation therapy for these patients and whether such treatment provides a significant oncologic benefit that outweighs the toxicities.
Methods And Materials: We gathered a panel of pediatric radiation oncologists from academic hospitals to identify and discuss current controversies regarding the role of radiation in the management of metastatic EWS and RMS. The panel reviewed existing clinical data and ongoing trials to address 5 key questions: (1) the role of whole lung irradiation (WLI) in treating lung metastases; (2) the number of metastatic sites warranting radiation therapy and the radicality of such an approach; (3) radiation techniques, including stereotactic body radiation therapy (SBRT); (4) the timing of metastatic-site radiation therapy; and (5) the utility of metastatic-site radiation therapy for relapsed metastatic disease.
Radiomics approach for identifying radiation-induced normal tissue toxicity in the lung.
Sci Rep
October 2024
Department of Radiation Oncology, University of California, Irvine, CA, 92697-2695, USA.
Article Synopsis
- Radiomics can effectively analyze features from both tumor and normal tissue to predict clinical outcomes, including the effects of radiation treatments and potential therapeutic benefits of human embryonic stem cell-derived extracellular vesicles (EVs).
- In a study involving 72 mice, researchers evaluated the impact of X-ray radiation on lung tissue and subsequently injected EVs, while extracting 851 radiomic features to train classification models predicting treatment outcomes.
- The study found that classification models achieved high accuracy in distinguishing between irradiated versus unirradiated groups and noted specific radiomic features that indicated the effects of radiation and the potential sparing effects of EV treatment.
Using Integrin αβ-Targeted Positron Emission Tomography Imaging to Longitudinally Monitor Radiation-Induced Pulmonary Fibrosis In Vivo.
Int J Radiat Oncol Biol Phys
September 2024
Department of Radiation Oncology, Washington University School of Medicine, St. Louis, Missouri. Electronic address:
Purpose: Radiation-induced pulmonary fibrosis (RIPF) is a potentially serious and disabling late complication of radiation therapy. Monitoring RIPF progression is challenging due to the absence of early detection tools and the difficulty in distinguishing RIPF from other lung diseases using standard imaging methods. In the lungs, integrin αvβ6 is crucial in the development of RIPF, acting as a significant activator of transforming growth factor β after radiation injury.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!